JP Morgan Chase
NVOS

JP Morgan Chase’s Novo Integrated Sciences, Inc. Common Stock NVOS Stock Holding History

JP Morgan Chase’s Portfolio NVOS Stock Details NVOS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q3 		– Sell
-43
Closed -$32 – 7845
2024
Q2 		$32 Buy
43
+3
+8% +$2 ﹤0.01% 7106
2024
Q1 		$19 Buy
40
+14
+54% +$9 ﹤0.01% 7179
2023
Q4 		$21 Buy
+26
New +$53 ﹤0.01% 7345

Other funds holding NVOS

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
HF
HRT Financial New York $40.1B AUM 58.22% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return
VF
Virtu Financial New York $2.41B AUM 48.35% 1-Year Est. Return
XT
XTX Topco George Town, Cayman Islands $5.75B AUM 30.56% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
Jane Street
Jane Street New York $777B AUM 61.18% 1-Year Est. Return

JP Morgan Chase's NVOS Position: Q3 2024 in Review

JP Morgan Chase sold out of Novo Integrated Sciences, Inc. Common Stock (NVOS) in Q3 2024, closing a stake of 43 shares — an estimated $32 sold.

JP Morgan Chase first reported a position in NVOS in Q4 2023 and held it in 3 quarters. The position peaked at $32 in Q2 2024. 16 funds tracked by Wall St. Rank hold NVOS as of Q3 2024.

  • JP Morgan Chase reported no remaining Novo Integrated Sciences, Inc. Common Stock position as of Q3 2024 after selling out during the quarter.
  • JP Morgan Chase sold 43 Novo Integrated Sciences, Inc. Common Stock shares in Q3 2024, an estimated $32.
  • JP Morgan Chase first reported a position in Novo Integrated Sciences, Inc. Common Stock in Q4 2023 and held it in 3 quarters.
  • JP Morgan Chase's Novo Integrated Sciences, Inc. Common Stock position peaked at $32 in Q2 2024.
  • 16 funds tracked by Wall St. Rank held Novo Integrated Sciences, Inc. Common Stock as of Q3 2024.

Based on JP Morgan Chase's 13F filing for Q3 2024, filed 8 Nov 2024.